A lawsuit over the antipsychotic drug Risperdal has led to an $8 billion punitive damages award against Johnson & Johnson and one of its subsidiaries.
A lawsuit over the antipsychotic drug Risperdal has led to an $8 billion punitive damages award against Johnson & Johnson and one of its subsidiaries.
The award was handed out Tuesday by a Philadelphia jury. The plaintiff's attorneys argued that the drug is linked to abnormal growth of female breast tissue in boys, theIn a statement, attorneys Tom Kline and Jason Itkin said Johnson & Johnson used an organized scheme to make billions of dollars while illegally marketing and promoting the drug.
Johnson & Johnson said the award is"excessive and unfounded" and that it would take immediate action to overturn it, the
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Johnson & Johnson hit as jury awards 'excessive' $8 billion in damagesShares of Johnson & Johnson dipped 2% on Wednesday after a jury awarded $8 billi...
Weiterlesen »
J&J Hit With $8 Billion Jury Award Over Antipsychotic DrugA Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Weiterlesen »
Johnson & Johnson Ordered To Pay $8 Million In Male Breast Growth CaseJ&J said it would appeal the decision.
Weiterlesen »
Jury says J&J must pay $8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Weiterlesen »
J&J must pay $8 billion in case over male breast growth linked to Risperdal: juryJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Weiterlesen »